15 research outputs found

    Human Stiff-Person Syndrome IgG Induces Anxious Behavior in Rats

    Get PDF
    Background: Anxiety is a heterogeneous behavioral domain playing a role in a variety of neuropsychiatric diseases. While anxiety is the cardinal symptom in disorders such as panic disorder, co-morbid anxious behavior can occur in a variety of diseases. Stiff person syndrome (SPS) is a CNS disorder characterized by increased muscle tone and prominent agoraphobia and anxiety. Most patients have high-titer antibodies against glutamate decarboxylase (GAD) 65. The pathogenic role of these autoantibodies is unclear. Methodology/Principal Findings: We re-investigated a 53 year old woman with SPS and profound anxiety for GABA-A receptor binding in the amygdala with (11)C-flumazenil PET scan and studied the potential pathogenic role of purified IgG from her plasma filtrates containing high-titer antibodies against GAD 65. We passively transferred the IgG fraction intrathecally into rats and analyzed the effects using behavioral and in vivo electrophysiological methods. In cell culture, we measured the effect of patient IgG on GABA release from hippocampal neurons. Repetitive intrathecal application of purified patient IgG in rats resulted in an anxious phenotype resembling the core symptoms of the patient. Patient IgG selectively bound to rat amygdala, hippocampus, and frontal cortical areas. In cultured rat hippocampal neurons, patient IgG inhibited GABA release. In line with these experimental results, the GABA-A receptor binding potential was reduced in the patient’s amygdala/hippocampus complex. No motor abnormalities were found in recipient rats. Conclusion/Significance: The observations in rats after passive transfer lead us to propose that anxiety-like behavior can be induced in rats by passive transfer of IgG from a SPS patient positive for anti-GAD 65 antibodies. Anxiety, in this case, thus may be an antibody-mediated phenomenon with consecutive disturbance of GABAergic signaling in the amygdala region

    Relative lipid packing between domains correlates with BD-GM1 partitioning.

    No full text
    <p>a) GP, BD-GM1 (green) and the disordered marker FAST-DiI (red) imaged in various membrane preparations. BD-GM1 and FAST-DiI are imaged in the same vesicle; GP is shown form a different vesicle representative of the preparation. b) The quantification of BD-GM1 ordered phase partitioning versus ΔGP.</p

    Membrane packing affects receptor-ligand binding.

    No full text
    <p>(a) CTxB binds (magenta) almost exclusively to the disordered domain pool of BD-GM1 (green) in phase separated GUVs and GPMVs where disordered phase is marked by FastDiI (red). (b) This behavior is quantified by the “CTxB binding to ordered domain”, the ratio between the phase localization of CTxB (K<sub>p,CTxB</sub>) and its receptor BD-GM1 (K<sub>p,GM1</sub>). (c) At high ΔGP, CTxB essentially does not recognize BD-GM1 present in the ordered domain; as the order difference between phases is reduced, recognition of CTxB in ordered phase increases. CTxB ordered binding is also well-correlated with disordered phase GP but not ordered phase GP. (d) Disordered domain binding of CTxB is preferential, but not exclusive, as ordered phase binding increases with increasing CTxB concentration for lower values of ΔGP.</p

    Various lipid mixtures yield a range of lipid packing states.

    No full text
    <p>(a) Natural PC mixtures (brain or liver PC extracts) yield liposomes with higher GP than synthetic DOPC bearing two unsaturated acyl chain. (b) Mixtures of cholesterol with natural SM (egg SM extract) and DPPC yield liposomes with lower order than cholesterol with pure SM 18:0. (c) Lipid packing of DOPC liposomes increases monotonically with increasing cholesterol. (d) Quantification of the effect of compositional variation on membrane order in one-phase liposomes.</p

    Tuning lipid packing in coexisting domains of GUVs and GPMVs.

    No full text
    <p>GP imaging of ordered and disordered phases in (a) DOPC:SSM:Chol GUVs with equimolar DOPC and SSM and varying Chol; (b) 2:2:1 GUVs with various ordering and disordering components; and (c) various GPMV preparations. In GPMVs, 0.5mM DCA lowers the GP of the disordered phase; [DTT] increases GP of the ordered and lowers GP of disordered. (d) Lipid packing (GP) of individual membrane domains and the differences (ΔGP) between ordered and disordered phases in phase separated membranes.</p
    corecore